HOME › DRUGS › IMLUNESTRANT
ACTIVE SUBSTANCE / INN

IMLUNESTRANT

Brand name(s): Inluriyo
EMA LISTED
AUTHORISED
Breast Neoplasms
ACTIVE SUBSTANCE
Imlunestrant
REGULATORS
EMA
SPONSORS / MAH
Eli Lilly Nederland B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
InluriyoEli Lilly Nederland B.V.Authorised09/01/2026Breast Neoplasms

FULL INTELLIGENCE ON IMLUNESTRANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →